2012 MASCC/ISOO Annual Meeting Study Group Workshops

Workshops:  2019  |  2018  |  2017  |  2016  |   2015  |  2014  |  2013  |  2012  |  2011 

Paving the Future of Supportive Cancer Care: Is E-Health the Way Forward?

This workshop provided an overview of various e-health technologies that can be applied to oncology and issues relevant to their adoption. It included a focus on best practices for clinical oncology practices and allowed participants a look at how e-health technologies can help in supportive cancer care. the workshop further provided an opportunity to forge research collaborations and share best practices.

  • Irma Verdonck-de Leeuw (The Netherlands). E-Health and Supportive Cancer Care: What’s New?
  • Alexandre Chan (Singapore). Patients’ Perceptions on the Cost-Effectiveness of E-Eealth Technologies: Where to Draw the Line?
  • Patrick Jahn (Germany), Designing “InterACTIV” E-Health Applications for Supportive Care – Putting Yourself in the Developer’s Shoes.
  • Afaf Girgis (Australia). The Role of E-Health in Facilitating Needs-Based Patient-Centered Care.
  • Mark Pasetka (Canada)  E-Health for Professionals: The “Needs” and “Wants” of Clinicians and Researchers. 
  • Kevin Yap (UK), Future of E-Health in Supportive Cancer Care: Can We Afford to Be Left Behind? 

Mucositis Research
Chair: Rajesh Lalla 

Sponsored by the Mucositis Study Group, this workshop included the presentation of original research by both early and experienced investigators on the pathogenesis and mechanisms of therapy-induced mucositis and clinical interventions. The workshop provided an informal venue for detailed discussion among investigators and thought leaders from around the world and fostered opportunities for research and collaboration. 

Session 1: Pathogenesis and Mechanisms
Chair: Wim Tissing

  • Abdul Rahman Al-Azri, Rachel Gibson, Joanne Bowen, Andrea Stringer, Dorothy Keefe, Richard Logan (Australia). The Role Of Matrix Metalloproteinases And Their Inhibitors In The Pathogenesis Of Chemotherapy-Induced Oral Mucositis: An Animal Model.
  • Margot Fijlstra, H. Schierbeek, G. Voortman, K.Y. Dorst, J.B. van Goudoever, E.H.H.M. Rings, W.J.E. Tissing (The Netherlands). The Intestine Prefers Basolateral Rather Than Apical Uptake Of Amino Acids To Meet Its Increased Amino Acid Utilization During Methotrexate-Induced Mucositis In The Rat.
  • Dan M.J. Milstein, Judith E. Raber-Durlacher, Jérôme A.H. Lindeboom, Bart J. Biemond, Jan de Lange (The Netherlands) .Different Oral Mucosal Microcirculatory Response In Two Separate Chemotherapy Regimens. 
  • Inger von Bültzingslöwen (Sweden) .Preclinical Studies On Oral Mucosal Immune Defense Mechanisms And Bacterial Dissemination.
  • Paolo Bossi, P. Filipazzi, C. Resteghini, R. Miceli, E. Orlandi, L. Locati, C. Bergamini, A. Mirabile, R. Granata, A. Cova, P. Squarcina, M. Rodolfo, C. Fallai, L. Rivoltini, L. Licitra (Italy). Salivary Cytokine Levels And Chemoradiotherapy-Induced Toxicities In Head And Neck Cancer Patients. 
  • E Bateman, J Bowen, A Wignall, E Yeoh and D Keefe (Australia). Development Of A Fractionated Radiotherapy Model To Investigate Acute And Chronic Radiation-Induced Gastrointestinal Injury In A Dark Agouti Rat Model. 

Session 2: Interventions for Mucositis
Chair: Dr. Nicole Blijlevens

  • Philippa Hawley, Allan Hovan, Colleen McGahan, Deborah Saunders (Canada). A Randomized Placebo-Controlled of Trial of Manuka Honey for Radiation- Induced Mucositis.
  • B. Pinel, E. Caillot, RJ Bensadoun (France). Using A Transcutaneous Applied LED Device In The Prevention And Treatment Of Mucositis Induced By Chemo-Radiotherapy For Head & Neck Cancer. 
  • R.R. Allison, R. Carmel, D.F. Ciuba, E. Feldman, W.M. Wisbeck, D.P. Nowotnik, S.T. Sonis, on behalf of the MuGard Trial Study Group (USA) Results From The Prospective, Multi‐Institutional, Double‐Blind, Sham‐Controlled Clinical Trial Of Mugard For Symptom Control Due To Mucositis In Chemoradiation-Treated Head And Neck Cancer Patients.
  • Barbara Murphy (USA). Phase 1b Study Assessing Safety, Tolerability And Efficacy Of AG013 In Subjects With Head And And Neck Cancer Receiving Induction Chemotherapy.
  • Carin Potting, Lenneke van Groningen, Koen Theunissen, Johan Maertens, Marinus van Marwijk Kooy, Harry Schouten, Otto Visser, Evelyne Willems, Anne Sonet, Nicole Blijlevens (The Netherlands).A Prospective Caphosol Audit For Prevention Of Oral Mucositis In Autologous Stem Cell Transplant Recipients After High-Dose Melphalan (CASH). 

Expert Panel Discussion
Recent Advances in Mucositis Research and Next Steps
Expert Panel Members: Nicole Blijlevens, Deborah McGuire, Cesar Migliorati, Mark Schubert, Wim Tissing.
Moderator: Sharon Elad

Enhancing Professional Confidence when Faced with Difficult Clinical Encounters  

This workshop, organized by the Psychosocial Study Group,  addressed the impact of stress and burnout in the oncology workforce and, in particular, the more subtle factors that can play a role, such as personality style, professional expectations, and training and confidence, especially in the psychosocial domain.  The workshop was designed to increase awareness and understanding of the determinants of stress and to provide opportunities to develop and practice new techniques for responding to challenging clinical encounters.

  • Jane Turner. Overview of stress and burnout and the emotional dimensions of the caring role in oncology.
  • Brian Kelly. Overview of challenging communications in oncology and strategies for response.
  • Case-based discussions based on participants’ clinical practice.

Management of GI and Nutritional Symptoms During and After Cancer Treatments

This workshop was designed to promote an understanding of the nature and frequency of GI and nutritional problems that arise during and after cancer treatments, causes for these problems, a look at current and future prevention strategies, and current treatment approaches.

  • Dorothy Keefe (Australia). Chemotherapy-Induced Toxicity: Why Does It Happen and What Can Be Done to Prevent and Treat It?
  • Linda Wedlake (UK). Radiotherapy-Induced GI Toxicity Is Really Caused by the “Consequential Effect,” not the Radiation. It Can All Be Prevented. 
  • Martin Hauer-Jensen (USA). Radiotherapy-Induced GI Toxicity: Pharmacological Approaches to Prevention.
  • Ann Muls (UK). Long-Term Impact of Cancer Treatments on GI Function: What Really Happens to Patients?
  • Clare Shaw (UK). Managing Chronic Nutritional Issues After Cancer Treatment: Who Should Be Managing the Patients: A Dietitian or a Gastroenterologist?
  • Joe Sellin (USA). Keynote Address: Are Bile Acid Malabsorption and Small Bowel Bacterial Overgrowth the Two Most Important, Easily Treatable But Ignored Causes of Severe Morbidity in Cancer Patients?
  • Joanne Bowen (Australia). TKI-Induced Diarrhoea
  • Stephen Sonis (USA). A New Approach to the Use of Genomics in Predicting Toxicity Risk.
  • Jervoise Andreyev (UK). A Practical Approach to Managing Patients: Some Clinical Cases and Panel Discussion.